Endo
- The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the UK
- Endo said it has signed a deal with Novavax and its unit Par Sterile has begun production of the final drug product
© 2026 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.









